Study Finds Birth Hypoxia May Increase ADHD Likelihood
January 27, 2026
Brand Name :
Supprelin LA
(United States) [Available]Synonyms :
histrelin
Class :
Antineoplastics and GnRH Antagonist
Dosage Forms & Strengths
Implant
50mg
50mcg/day
50 mg implant given SC for every 12 months
The maximum duration of treatment includes removing the implant after 12 months
Dose Adjustments
Renal Impairment:
Dose adjustment not required
Liver impairment:
No data available
Dosage Forms & Strengths
Implant
50mg
65mcg/day
age: >2 years
50 mg implant given SC for every 12 months
The maximum duration of treatment includes removing the implant after 12 months
when both drugs are combined, there may be increased toxicity of nilotinib by qtc interval
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
QTc interval is increased both by lenvatinib and histrelin
Progestins may reduce the therapeutic efficacy
when both drugs are combined, there may be a reduced therapeutic efficacy of albiglutide
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
it may diminish the excretion rate when combined with interleukins, resulting in an enhanced serum level
it may diminish the excretion rate when combined with interleukins, resulting in an enhanced serum level
it may diminish the excretion rate when combined with interleukins, resulting in an enhanced serum level
it may diminish the excretion rate when combined with Zinc, resulting in an enhanced serum level
it may diminish the excretion rate when combined with Zinc, resulting in an enhanced serum level
it may diminish the excretion rate when combined with Zinc, resulting in an enhanced serum level
it may diminish the excretion rate when combined with Zinc, resulting in an enhanced serum level
it may diminish the excretion rate when combined with Zinc, resulting in an enhanced serum level
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
It may enhance the risk of adverse effects when combined with Progestins
when both drugs are combined, there may be an increased risk or severity of QTC prolongation
Adverse drug reactions
Frequency defined
>10%
Hot flashes
1-10%
Anemia
Constipation
Decreased libido
Erectile dysfunction
Fatigue
Headache
Insomnia
Weight gain
Gynecomastia
Testicular atrophy
Hepatic disorder
Implant site reaction
Pregnancy warnings:
Breastfeeding warnings:
Pregnancy Categories:
Patient Information Leaflet
Generic Name: histrelin (Rx)
Pronounced: hiss -tre-lin
Why do we use histrelin?
histrelin is an anticancer drug, and GnRH agonist used to treat central precocious puberty and advanced prostate cancer.